Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma

Clinical trial NCT04899414 · UNKNOWN

Trial details

NCT number: NCT04899414
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

NK/T Cell Lymphoma

Start date: 2021-05-18
Primary completion: 2023-05-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.